In an in vitro approach (Itoshima et al., 2000), esophageal cancer cells were transfected with a plasmid designed to rise ARF expression (exogenous), with the subsequent reduction of endogenous levels of Mdm2 and induced p53 accumulation. Here, CDKN2A is linked to esophageal cancer.